Economic consequences of multiple sclerosis for Canadians

Acta Neurologica Scandinavica

Volumn 95, Issue 5, 1997, Pages 268-274

  Asche, C V ^a,b,f   Ho, E ^a   Chan, B ^a,c,d   Coyte, P C ^a,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c Price Waterhouse   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canada; Cast of illness; Cost and cost analysis; Health care costs; Health expenditures; Multiple sclerosis; Prevalence

Indexed keywords

ARTICLE; CANADA; DECISION MAKING; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 0030924895     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00208.x     Document Type: Article

References (41)

1. Multiple Sclerosis (MS) Society of Canada. Planning study - MS Society Ottawa - Carleton Chapter, 1994.
2. HOLMES J, MADGWICK T, BATES D. The cost of multiple sclerosis. Br J Med Econ 1995: 8: 181-93.
3. KORNBLITH AB, LA ROCCA NG, BAUM HM. Employment in individuals with multiple sclerosis. Int J Rehab Research 1986: 9(2): 155-65.
4. CATANZARO M, WEINERT C. Economic status of families living with multiple sclerosis. Int J Rehabil Res 1992: 15: 209-18.
5. LAROCCA N, KALB R, SCHEINBERG L, KENDALL R. Factors associated with unemployment of patients. J Chron Dis 1985: 38(2): 203-10.
6. BOURDETTE DN, BROCHAZKA AV, MITCHELL W, LICARI P, BURKS J. Arch Phys Med Rehabil 1993: 74: 26-31.
7. KURTZKE JF. A reassessment of the distribution of multiple sclerosis. Part I. Acta Neurol Scand 1995: 51: 110-36.
8. KURTZKE JF. Multiple sclerosis: changing times. Neuroepidemiology 1991: 10: 10-8.
9. SWEENEY VP, SADOVINICK AD, BRANDEJS V. Prevalence of multiple sclerosis in British Columbia. Can J Neurol Sci 1986: 13: 47-51.
10. HADER WJ, ELLIOT M, EBERS GC. Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada. Neurology 1988: 38: 617-21.
11. HADER WJ. Prevalence of multiple sclerosis in Saskatoon. Can Med Assoc J 1982: 149: 295-7.
12. PRYSE-PHILLIPS WEM. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-1984. Ann Neurol 1986: 20; 323-8.
13. SADOVNICK AD, EBERS GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neuro Sci 1993: 20(1): 17-29.
14. ROBERTS JHW, MARTIN JP, MCLELLAN DL, MCINTOSH-MICHAELIS SA, SPACKMAN AJ. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority. J Neurol Neurosurg Psychiatry 1991: 54: 55-9.
15. MCFARLIN DE, MCFARLAND HF. Multiple sclerosis. Part I. New Eng J Med 1982: 307(19): 1183-8.
16. ERIGENSON JS. The cost-effectiveness of multiple sclerosis rehabilitation: A model. Neurology 1981: 31: 1316-22.
17. CREWE NM, ATHELSTAN GT. Functional assessment in vocational rehabilitation: a systematic approach to diagnosis and goal setting. Arch Phys Med Rehab 1981: 62: 299-305.
18. FORER SK, MILLER LS. Rehabilitation outcome: comparative analysis of different patient types. Arch Phys Med Rehab 1980: 61: 359-65.
19. Statistics Canada. Canadian Economic Observer, 1995. July. (Cat. No. 11-010.)
20. Health Canada. National Health Expenditures in Canada: 1975-1993. Ottawa: Supply and Services Canada, 1994. (Catalogue No. H21-99.)
21. SHUM JA. Drug management of MS. The CE Advisor. Hospital Pharmacy Practice 1994: 1(1).
22. MCGOWN KL, MCWHINNIE L. MS patient survey. Concordia University Pharmaceutical Management Centre. Montreal. Quebec. October, 1995 (unpublished).
23. Statistics Canada. Hospital Statistics: Preliminary Annual Report, 1993-1994. Ottawa: Supply and Services Canada, Special Request Unit, 1996 (unpublished).
24. Statistics Canada. Residential Care Facilities - Aged, 1992-1993. Ottawa: Supply and Services Canada, 1994. (Catalogue No. 83-237.)
25. Manitoba Health. Annual Report: 1993-1994. Winnipeg: Manitoba Health, 1994.
26. Manitoba Health. Special Request. Winnipeg: Manitoba Health, 1996 (unpublished).
27. ROBINSON JC. Philosophical origins of the economic evaluation of life. Millbank Quarterly 1986: 64(1): 133-5.
28. HODGSON T, MEINERS M. Cost of illness methodology: a guide to current practices and procedures. Millbank Quarterly 1982: 60(3): 429-62.
29. Statistics Canada. Causes of death. 1993-1994. Ottawa: Supply and Services Canada. Special Request Unit. 1996 (unpublished).
30. Statistics Canada. Income distributions by size in Canada, 1993. Ottawa: Statistics Canada, Household Surveys Division, 1994. (Catalogue No. 13-207.)
31. Statistics Canada. Labour force activity, 1991 census. Ottawa: Statistics Canada, Health Statistics Division, 1994.
32. SCULPHER MJ, BUXTON MJ, FERGUSON BA, SPIEFELHALTER DJ, KIRBY AJ. Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ 1992: 1: 39-51.
33. TORGENSON DJ, DONALDSON C, REID DM. Private versus social opportunity cost of time: valuing time in the demand for health care. Health Econ 1994: 3: 149-55.
34. Ontario Ministry of Health: Ontario Health Survey (OHS) User's Guide, Vol. 2. Microdata Manual, Toronto, Queen's Printer, 1993.
35. WIGLE DT, MAO Y, WONG, T, LANE R. Economic burden of illness in Canada, 1986. Chron Dis Can 1991: 12(Suppl. 2): 1-37.
36. WILKINS R, ADAMS OB. Healthfulness of Life: A unified view of mortality, institutionalization, and non-institutionalized disability in Canada, 1978. Montreal: The Institute for Research on Public Policy, 1983.
37. CHAN B, COYTE PC, HEICK C. Economic impact of cardiovascular disease in Canada. Can J Cardiol 12(10): 1996.
38. SCITOVSKY AA. Estimating the direct costs of illness. Millbank Quarterly 1982: 60(3): 463-91.
39. SHEILL A, GERARD K, DONALDSON C. Cost-of-illness studies: no aid to decision making? Reply to: Sheill et al. (Health Policy 1987: 8: 317-23) Health Policy 1988: 10: 137-41.
40. BEHRENS C, HENKE KD. Cost-of-illness studies: no aid to decision making? Reply to: Sheill et al. (Health Policy 1987: 8: 317-23) Health Policy 1988: 10: 137-41.
41. HODGSON TA. Cost-of-illness studies: no aid to decision making? Comment on the second opinion by Sheill et al. (Health Policy 1987: 8: 317-23) Health Policy; 11: 57-60.